-
1
المؤلفون: Barbara Burtness, Loren K. Mell, Neck Cancer Intergroup, Jean Bourhis, Stefan Michiels, Catherine Fortpied, Federico Rotolo, Brian O'Sullivan, Giuseppe Sanguineti, Jonathan Harris, Hanjie Shen, March, Maria Grazia Ghi, Benjamin Lacas, Lucas K. Vitzthum, Vincent Grégoire, Jens Overgaard, Mahesh K. B. Parmar, Kaveh Zakeri, Quynh-Thu Le, Allan Hackshaw, Björn Zackrisson, Jean-Pierre Pignon
المصدر: Zakeri, K, Rotolo, F, Lacas, B, Vitzthum, L K, Le, Q T, Gregoire, V, Overgaard, J, Hackshaw, A, Zackrisson, B, Parmar, M K B, Burtness, B A, Ghi, M G, Sanguineti, G, O’Sullivan, B, Fortpied, C, Bourhis, J, Shen, H, Harris, J, Michiels, S, Pignon, J P, Mell, L K & for the MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer Intergroup 2020, ' Predictive classifier for intensive treatment of head and neck cancer ', Cancer, vol. 126, no. 24, pp. 5263-5273 . https://doi.org/10.1002/cncr.33212Test
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, altered fractionation, chemotherapy, law.invention, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Randomized controlled trial, law, Internal medicine, medicine, Humans, 030212 general & internal medicine, Randomized Controlled Trials as Topic, competing risks, Chemotherapy, Radiotherapy, Performance status, Squamous Cell Carcinoma of Head and Neck, business.industry, Intensive treatment, Head and neck cancer, Hazard ratio, Age Factors, Middle Aged, medicine.disease, Survival Analysis, Confidence interval, Radiation therapy, Treatment Outcome, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Female, head and neck cancer, Dose Fractionation, Radiation, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f34f9d6dc15c16a220b1f7d219f991Test
https://doi.org/10.1002/cncr.33212Test -
2
المؤلفون: Pier Luigi Zinzani, Julien Depaus, P. Valagussa, Simonetta Viviani, Patrice Carde, Laurianne Clément-Filliatre, Jonathan Douxfils, Marc André, Olivier Casasnovas, Massimo Federico, Pauline Brice, Nicolas Mounier, Alessandro M. Gianni, Paolo G. Gobbi, Jehan Dupuis, Catherine Fortpied, Martin Hutchings, Emilio Iannitto, Monica Bellei, Marian Heczko, Alessandro Rambaldi, Josette Brière
المساهمون: Andre M.P.E., Carde P., Viviani S., Bellei M., Fortpied C., Hutchings M., Gianni A.M., Brice P., Casasnovas O., Gobbi P.G., Zinzani P.L., Dupuis J., Iannitto E., Rambaldi A., Briere J., Clement-Filliatre L., Heczko M., Valagussa P., Douxfils J., Depaus J., Federico M., Mounier N., UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
المصدر: Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298Test
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)مصطلحات موضوعية: 0301 basic medicine, BEACOPP, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Procarbazine, 0302 clinical medicine, International Prognostic Index, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Original Research, Etoposide, Randomized Controlled Trials as Topic, Hazard ratio, Neoplasms, Second Primary, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hodgkin Disease, Dacarbazine, Vincristine, 030220 oncology & carcinogenesis, Disease Progression, secondary cancers, Female, medicine.drug, Adult, medicine.medical_specialty, ABVD, Hodgkin lymphoma, overall survival, progression-free survival, Adolescent, Vinblastine, Risk Assessment, Transplantation, Autologous, lcsh:RC254-282, 03 medical and health sciences, Bleomycin, Young Adult, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Progression-free survival, Cyclophosphamide, Aged, business.industry, Clinical Cancer Research, progression‐free survival, 030104 developmental biology, Clinical Trials, Phase III as Topic, Doxorubicin, Prednisone, business, Stem Cell Transplantation
وصف الملف: STAMPA; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99be92d20b893ec3b515374f66c11fcTest
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29aTest -
3
المؤلفون: Carla M.L. van Herpen, Marie Vinches, Catherine Fortpied, Éva Remenár, Petr Szturz, Cyril Abdeddaim, John S. Stewart, Jan B. Vermorken
المصدر: European Journal of Cancer, 156, 109-118
European Journal of Cancer, 156, pp. 109-118
European journal of cancerمصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Time Factors, Databases, Factual, medicine.medical_treatment, Docetaxel, Gastroenterology, Risk Assessment, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Feeding tube, Aged, Retrospective Studies, business.industry, Squamous Cell Carcinoma of Head and Neck, Head and neck cancer, Hazard ratio, Induction chemotherapy, Middle Aged, medicine.disease, Dysphagia, Progression-Free Survival, Radiation therapy, Europe, Oncology, Clinical Trials, Phase III as Topic, Head and Neck Neoplasms, Disease Progression, Female, Human medicine, Fluorouracil, medicine.symptom, Cisplatin, business, PF Regimen, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b9beeda7988f0755536e301dad808aTest
https://pubmed.ncbi.nlm.nih.gov/34425403Test -
4
المؤلفون: Brian O'Sullivan, Everett E. Vokes, J. Bernier, J. Vermorken, Jean-Jacques Mazeron, J.W. Lee, J. Simes, Carlo Fallai, P. Olmi, Cai Grau, K.H. Cho, B. Lacas, J.J. Cruz Hernandez, P. Graff-Cailleaud, Branislav Jeremic, J. Overgaard, Giuseppe Sanguineti, J.H. Hay, Voichita Bar-Ad, B. Gery, H. Quon, W. Dobrowsky, B. Maciejewski, M. Nankivell, Catherine Fortpied, Y. Belkacemi, Z. Szutkowski, V. Budach, David J. Adelstein, Maria Grazia Ghi, Allan Hackshaw, A. Trotti, Vincent Grégoire, Jens Overgaard, P. Blanchard, David I. Rosenthal, B. O'Sullivan, B.G. Haffty, Ju-Whei Lee, E. Moyal, M. Alfonsi, O. Choussy, S. Kumar, Barbara Burtness, M. Cheugoua-Zanetsie, C.M.P. Viegas, V. Tseroni, E. Lartigau, H. Bartelink, Björn Zackrisson, Jean-Pierre Pignon, S. Staar, J. Waldron, J.S. Wu, A. Lopes, M.G. Ghi, Sarbani Ghosh Laskar, Lisa Licitra, K.D Wernecke, C. Grau, Y.G. Tao, J. Agarwal, Yoann Pointreau, Maurice Cheugoua-Zanetsie, M. Lotayef, G. Calais, Claire Petit, J. Moon, J.A. Langendijk, C.A. Kristensen, W. Budach, Mahesh K.B. Parmar, Mahesh K. B. Parmar, Athanassios Argiris, Benjamin Lacas, C. Sire, S. Spencer, Beth M. Beadle, C. Petit, John Simes, Michael Poulsen, Arlene A. Forastiere, Q.T. Le, Adam S. Garden, L.P. Zhong, J.J. Mazeron, H. van Tinteren, Å. Bratland, Jean Pierre Pignon, Yi Li, Jeffrey S Tobias, S.H. Moon, P. Strojan, J. Bourhis, S. Temam, A. Bacigalupo, Pedro A. Torres-Saavedra, E.E. Vokes, C.M.L. Driessen, Stéphane Temam, M.M Dominello, E. Chamorey, J. Widder, Ricardo Hitt, C. van Herpen, Séverine Racadot, M. Julieron, H. Yamazaki, Rafał Suwiński, Z. Takácsi-Nagy, A. Hansen, K. Skladowski, D. Chaukar, P. Lee, S. Hayoz, F. Lewin, Marshall R. Posner, Atul Sharma, S. Mehta, M.G. Poulsen, S. Ghosh Laskar, R. Suwinski, B. Campbell, Wojciech Michalski, Jimmy J. Caudell, Jørgen Johansen, C. Simon, C. Fortpied, R. Orecchia, Volker Budach, George Shenouda, V. Torri, Shaleen Kumar, E Haddad, P. Rovea, P. Torres-Saavedra, Juan Jesús Cruz Hernández, Lai-Ping Zhong, Quynh-Thu Le, B. Zaktonik, J.W. Denham, A. Aupérin, B. Zackrisson, Gregory T. Wolf, J.C. Horiot, C. Stromberger, Jean Bourhis, S. Chabaud, Michel Lapeyre, Eric Lartigau, S.J. Wong, George Fountzilas, P. Nilsson, David M. Brizel, M.R. Posner, L. Tripcony, René-Jean Bensadoun, C. Jones, M.G. Ruo Redda, Pierre Blanchard, D. Thomson, A. Hackshaw, B. Jeremic, G. Sanguineti, Pirus Ghadjar, A. Auperin, P. Garaud
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Lancet Oncology, 22, 727-736
Petit, C, Lacas, B, Pignon, J-P, Le, Q T, Grégoire, V, Grau, C, Hackshaw, A, Zackrisson, B, Parmar, M K B, Lee, J-W, Ghi, M G, Sanguineti, G, Temam, S, Cheugoua-Zanetsie, M, O'Sullivan, B, Posner, M R, Vokes, E E, Cruz Hernandez, J J, Szutkowski, Z, Lartigau, E, Budach, V, Suwiński, R, Poulsen, M, Kumar, S, Ghosh Laskar, S, Mazeron, J-J, Jeremic, B, Simes, J, Zhong, L-P, Overgaard, J, Fortpied, C, Torres-Saavedra, P, Bourhis, J, Aupérin, A, Blanchard, P & MACH-NC and MARCH Collaborative Groups 2021, ' Chemotherapy and radiotherapy in locally advanced head and neck cancer : an individual patient data network meta-analysis ', The Lancet Oncology, vol. 22, no. 5, pp. 727-736 . https://doi.org/10.1016/S1470-2045Test(21)00076-0
The Lancet Oncology, 22(5), 727-736. ELSEVIER SCIENCE INC
Lancet Oncology, 22, 5, pp. 727-736
Petit, C, Lacas, B, Pignon, J P, Le, Q T, Grégoire, V, Grau, C, Hackshaw, A, Zackrisson, B, Parmar, M K B, Lee, J W, Ghi, M G, Sanguineti, G, Temam, S, Cheugoua-Zanetsie, M, O'Sullivan, B, Posner, M R, Vokes, E E, Cruz Hernandez, J J, Szutkowski, Z, Lartigau, E, Budach, V, Suwiński, R, Poulsen, M, Kumar, S, Ghosh Laskar, S, Mazeron, J J, Jeremic, B, Simes, J, Zhong, L P, Overgaard, J, Fortpied, C, Torres-Saavedra, P, Bourhis, J, Aupérin, A, Blanchard, P, MACH-NC and MARCH Collaborative Groups & Johansen, J 2021, ' Chemotherapy and radiotherapy in locally advanced head and neck cancer : an individual patient data network meta-analysis ', The Lancet Oncology, vol. 22, no. 5, pp. 727-736 . https://doi.org/10.1016/S1470-2045Test(21)00076-0مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Network Meta-Analysis, Head and Neck Neoplasms/mortality, chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, head and neck cancer, radiotherapy, chemotherapy, radiochemotherapy, 030212 general & internal medicine, radiotherapy, business.industry, Head and neck cancer, Hazard ratio, Dose fractionation, Induction chemotherapy, Cancer, Chemoradiotherapy, medicine.disease, Radiation therapy, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Concomitant, Female, head and neck cancer, radiochemotherapy, Dose Fractionation, Radiation, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1259a72c5e0b5c71717fac9506bddb8Test
http://hdl.handle.net/2066/235407Test -
5
المؤلفون: Neck Cancer Intergroup, Allan Hackshaw, Björn Zackrisson, Jean-Pierre Pignon, Maria Grazia Ghi, Mahesh K. B. Parmar, Benjamin Lacas, Catherine Fortpied, Brian O'Sullivan, Mach-Nc Collaborative, Vincent Grégoire, Quynh-Thu Le, Giuseppe Sanguineti, Stefan Michiels, Kaveh Zakeri, Federico Rotolo, Jean Bourhis, Barbara Burtness, Lucas K. Vitzthum, Jonathan Harris, Hanjie Shen, Jens Overgaard, Loren K. Mell
المصدر: SSRN Electronic Journal.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, Performance status, business.industry, medicine.medical_treatment, Intensive treatment, Head and neck cancer, Hazard ratio, Cancer, medicine.disease, Confidence interval, law.invention, Randomized controlled trial, law, Internal medicine, medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::67bd881fbd8cbd219cbc069ade8a59a3Test
https://doi.org/10.2139/ssrn.3420420Test -
6
المؤلفون: Pauline Brice, Anne-Ségolène Cottereau, Anne-Claire Gac, Marc André, Catherine Fortpied, Massimo Federico, Julien Lazarovici, Cédric Rossi, René-Olivier Casasnovas, Sarah Bailly, Clémentine Joubert, Luc Mathieu Fornecker, Bénédicte Deau-Fisher, Salim Kanoun, Michel Meignan, Herve Ghesquieres, Marie Maerevoet, Aspasia Stamatoullas, John M.M. Raemakers
المصدر: Blood. 134:128-128
مصطلحات موضوعية: BEACOPP, medicine.medical_specialty, Univariate analysis, business.industry, medicine.medical_treatment, Immunology, Hazard ratio, Retrospective cohort study, Cell Biology, Hematology, Biochemistry, law.invention, Randomized controlled trial, ABVD, law, Internal medicine, Cohort, medicine, Stage iib, business, health care economics and organizations, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dc759a6ddbb257a0c952cbac0f7e8e4eTest
https://doi.org/10.1182/blood-2019-125976Test -
7
المؤلفون: Alessandro Pulsoni, Vitaliana De Sanctis, Massimo Federico, Peter Hoskin, Pinuccia Valagussa, Ina Monsef, Ingrid Becker, Nicholas Chadwick, Monica Bellei, Stefano Luminari, Alessandro M. Gianni, Catherine Fortpied, Andreas Engert, Peter Johnson, Simonetta Viviani, Dennis A. Eichenauer, Michel Henry-Amar, Matthew R. Sydes, Jeremy Franklin
المصدر: Eichenauer, D A, Becker, I, Monsef, I, Chadwick, N, de Sanctis, V, Federico, M, Fortpied, C, Gianni, A M, Henry-Amar, M, Hoskin, P, Johnson, P, Luminari, S, Bellei, M, Pulsoni, A, Sydes, M R, Valagussa, P, Viviani, S, Engert, A & Franklin, J 2017, ' Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma : a systematic review and meta-analysis of randomized clinical trials ', Haematologica, vol. 102, no. 10, pp. 1748-1757 . https://doi.org/10.3324/haematol.2017.167478Test
Haematologicaمصطلحات موضوعية: Oncology, Hodgkin Disease/mortality, medicine.medical_specialty, medicine.medical_treatment, Article, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Odds Ratio, Humans, Progression-free survival, Combined Modality Therapy/adverse effects, Proportional Hazards Models, Randomized Controlled Trials as Topic, Chemotherapy, Manchester Cancer Research Centre, Hodgkin Lymphoma, Proportional hazards model, business.industry, Myelodysplastic syndromes, Antineoplastic Combined Chemotherapy Protocols/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, Hazard ratio, Neoplasms, Second Primary, Odds ratio, Hematology, medicine.disease, Combined Modality Therapy, Hodgkin Disease, Neoplasms, Second Primary/etiology, Surgery, Radiation therapy, Second Primary, 030220 oncology & carcinogenesis, Follow-Up Studies, business, 030215 immunology
وصف الملف: application/pdf; text
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee146e782c426656e9acb1b4e25ef1cTest
https://doi.org/10.3324/haematol.2017.167478Test -
8
المؤلفون: Anat Gafter-Gvili, Bernice Oberman, Maria Gomes da Silva, Marinus H. J. van Oers, Peter Dreger, Umberto Vitolo, Michele Ghielmini, Ofer Shpilberg, Mathias Witzens-Harig, Thomas M. Habermann, Liat Vidal, Laurence S. Freedman, Carmit Rubin, Hailun Li, Catherine Fortpied, Andrea Evangelista, Sami Bousseta, Ruth Pettengell, Gilles Salles
المساهمون: Electrical Engineering University of Leeds, Service d'hématologie [Hôpital Edouard Herriot - HCL], Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon ( HCL ) -Hospices Civils de Lyon ( HCL ), Centre de Recherche en Cancérologie de Lyon ( CRCL ), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Science for Life Laboratory Uppsala, Department of Medical Biochemistry and Microbiology, Uppsala University, Hematology, Academic Medical Center [Amsterdam] ( AMC ), University of Amsterdam [Amsterdam] ( UvA ) -University of Amsterdam [Amsterdam] ( UvA ), European Organisation for Research and Treatment of Cancer [Bruxelles] ( EORTC ), European Cancer Organisation [Bruxelles] ( ECCO ), Innere Medizin V, Medizinische Universitäts-Klinik und Poliklinik, Heidelberg University Hospital [Heidelberg], Instituto Português de Oncologia de Lisboa Francisco Gentil, China Agricultural University ( CAU ), Shanghai Jiao Tong University [Shanghai], Clinical Haematology
المصدر: European journal of cancer (Oxford, England : 1990)
European journal of cancer (Oxford, England : 1990), 2017, 76 (17), pp.216-225
European journal of cancer (Oxford, England, 76, 216-225. Elsevier Limitedمصطلحات موضوعية: Male, Oncology, Cancer Research, Follicular lymphoma, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Follicular, Randomized Controlled Trials as Topic, Aged, 80 and over, Hazard ratio, Induction Chemotherapy, Middle Aged, Survival Rate, Vincristine, 030220 oncology & carcinogenesis, Meta-analysis, Female, Rituximab, medicine.drug, Adult, medicine.medical_specialty, Maintenance, Antineoplastic Agents, Induction Phase, Infections, Disease-Free Survival, Maintenance Chemotherapy, Immunocompromised Host, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Overall survival, Humans, Adverse effect, Cyclophosphamide, Aged, Proportional Hazards Models, business.industry, Patient data, medicine.disease, Surgery, Doxorubicin, Multivariate Analysis, Prednisone, business, 030215 immunology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98e169ea2c5ae06e30694e469de7179Test
https://hal.archives-ouvertes.fr/hal-01568667Test -
9
المؤلفون: Maria Gomes da Silva, Ruth Pettengell, Carmit Rubin, Bernice Oberman, Peter Dreger, Sami Bousseta, Hailun Li, Ofer Shpilberg, Umberto Vitolo, Gilles Salles, Laurence S. Freedman, Mathias Witzens-Harig, Thomas M. Habermann, Liat Vidal, Anat Gafter-Gvili, Marinus H. J. van Oers, Catherine Fortpied, Andrea Evangelista
المصدر: Blood. 124:4462-4462
مصطلحات موضوعية: medicine.medical_specialty, Performance status, business.industry, Immunology, Hazard ratio, Cell Biology, Hematology, Biochemistry, Chemotherapy regimen, Surgery, law.invention, Log-rank test, Maintenance therapy, Randomized controlled trial, Median follow-up, law, Internal medicine, medicine, Progression-free survival, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ac24a38445f1d28ad0b6aede9232d104Test
https://doi.org/10.1182/blood.v124.21.4462.4462Test -
10
المؤلفون: Pauline Brice, Richard W.M. van der Maazen, Marc André, John M. M. Raemaekers, T. Girinski, Monica Bellei, Massimo Federico, Annibale Versari, Christophe Fermé, Michel Meignan, Oumedaly Reman, Catherine Fortpied, Catherine Sebban, Martin Hutchings, Aspasia Stamatoulas, Franck Morschhauser, Elly Lugtenburg, Ercole Brusamolino
المصدر: Blood. 120:549-549
مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.medical_treatment, Standard treatment, Immunology, Hazard ratio, Cell Biology, Hematology, Interim analysis, Biochemistry, Chemotherapy regimen, Radiation therapy, ABVD, Statistical significance, Medicine, Radiology, Stage (cooking), business, Nuclear medicine, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0c487ddcdb2b69cef6d48eac788b2d30Test
https://doi.org/10.1182/blood.v120.21.549.549Test